Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes.

TG Brott, EC Haley Jr, DE Levy, W Barsan, J Broderick… - Stroke, 1992 - Am Heart Assoc
Thrombolytic agents hold theoretical promise as therapy for cerebral infarction. This study
was designed to evaluate the safety of tissue plasminogen activator, to accomplish urgent …

Bivalirudin: an anticoagulant for acute coronary syndromes and coronary interventions

HD White, DP Chew - Expert opinion on pharmacotherapy, 2002 - Taylor & Francis
Heparin is a commonly used anticoagulant in patients with coronary artery disease but its
use does not always result in low rates of ischaemic and bleeding events, so the search for …

[HTML][HTML] Optimization and high level production of recombinant synthetic Streptokinase in E. coli using Response Surface Methodology

M Aghaeepoor, A Akbarzadeh, F Kobarfard… - Iranian journal of …, 2019 - ncbi.nlm.nih.gov
Streptokinase (SK) is an extracellular protein comprising 414 amino acids with considerable
clinical importance as a commonly used thrombolytic agent. Due to its wide spread …

[PDF][PDF] ЭФФЕКТИВНОСТЬ И БЕЗОПАСНОСТЬ ТРОМБОЛИТИЧЕСКОЙ ТЕРАПИИ ПРИ ИЛЕОФЕМОРАЛЬНОПОПЛИТЕАЛЬНОМ ТРОМБОЗЕ

ЮА Безлепкин - almazovcentre.ru
Тромбоз глубоких вен (ТГВ) нижних конечностей и тромбоэмболия легочных артерий
(ТЭЛА) представляют одну из важнейших проблем и занимают одно из первых мест в …

Fibrinolytic Therapy with tPA Failed Because it was Based on a Flawed Concept

V Gurewich - Journal of Cardiology & Cardiovascular Therapy, 2018 - ideas.repec.org
Fibrinolytic Therapy with tPA Failed Because it was Based on a Flawed Concept IDEAS home
Advanced search Economic literature: papers, articles, software, chapters, books. Authors …

[引用][C] Urgent Therapy for Stroke

J Broderick, GL Sheppard, J Spilker, GL Kongable… - 1992